Early Introduction of Allergenic Foods for Food Allergy Prevention: What the Evidence Shows

Ecological and population-based studies are now confirming that the paradigm shift in infant feeding is translating into measurable public health gains. The Australian EarlyNuts study compared peanut allergy prevalence in 1,933 infants born in 2018–2019 (after guideline changes) with 5,276 infants from the earlier HealthNuts cohort (2007–2011) and found a 16% reduction in peanut allergy prevalence attributable to earlier peanut introduction.

In the United States, Gabryszewski and colleagues published the largest outcomes analysis to date in Pediatrics (November 2025). Using electronic health records from the AAP CER2 network, they compared IgE-mediated food allergy diagnoses across three eras: pre-guidelines, post-initial guidelines (2015), and post-addendum guidelines (2017). The results were striking: peanut allergy diagnoses declined by 43% (from 0.79% to 0.45%) and any IgE-mediated food allergy by 29% (from 1.46% to 0.93%) between the pre-guidelines and post-addendum periods. The authors estimated that for approximately every 200 infants exposed to allergens early, one child was prevented from developing food allergy.

Revised Swedish infant feeding guidelines were similarly associated with significantly earlier introduction of allergenic foods in a national cohort, though allergy outcome data from that population are not yet mature enough to confirm a prevalence reduction.

Whether early introduction benefits infants without eczema or egg allergy — the general population — remains a more nuanced question. The EAT trial enrolled exclusively from the general population, and its ITT analysis was negative. The PreventADALL trial in Northern Europe, a large cluster-randomised study of 2,397 infants, introduced peanut, milk, wheat, and egg from 3 months of age. While the intervention reduced food allergy at 36 months, the NNT was 63 — meaning many low-risk infants need to be exposed to prevent one case.

Several experts have argued that even a modest individual benefit, when applied at the population level, produces meaningful public health returns because of the sheer number of infants involved. Observational data showing that each additional food introduced during the first 6 months was associated with a 10.8% decrease in food allergy risk before age 10 support a broader benefit. Current guidelines from AAAAI/ACAAI/CSACI (2021) and the Dietary Guidelines for Americans (2020–2025) now recommend early introduction for all infants — not just those at high risk — reflecting a shift toward universal prevention.

A consistent finding across the evidence is that one-time or intermittent early exposure may be insufficient. The gap between ITT and per-protocol results in the EAT trial underscores this point: families who actually maintained regular consumption of allergenic foods saw significant benefits, while those with poor adherence did not.

Recent guideline updates explicitly emphasise that allergenic foods must be consumed regularly — ideally several times per week — after initial introduction. Intermittent exposure to cow’s milk formula in early infancy, for example, has been associated with increased rather than decreased risk of cow’s milk allergy, while regular formula supplementation appears protective. This dose-response relationship has important practical implications: recommending introduction without supporting sustained consumption may dilute the preventive effect.

The LEAP-Trio findings, however, offer an important nuance: once tolerance is established through the critical early window (the first 5 years in the LEAP protocol), the protection appears to be remarkably durable even with variable subsequent consumption. This suggests that the early window of introduction and initial sustained exposure is the critical period, after which immunological memory may maintain protection more independently.

Despite strong evidence and updated guidelines, adoption of early allergenic food introduction remains suboptimal. A 2025 US survey by Shen and colleagues found that fear of allergic reactions was the most commonly cited barrier, followed by inconsistent or absent guidance from paediatricians, practical difficulties preparing age-appropriate textures, and cultural or religious dietary restrictions.

On the provider side, only 76% of paediatricians and 52% of family physicians were aware of peanut prevention guidelines as of recent surveys. This knowledge gap translates directly into missed opportunities during well-child visits. Families who receive no proactive counselling about early introduction are far less likely to attempt it on their own, particularly if they have a family history of allergies and carry heightened anxiety about reactions.

Several implementation strategies are showing promise: in-clinic first-feeding programmes where infants receive their first exposure to peanut under medical supervision, use of commercially available infant peanut products designed for easy mixing with purees, and integration of allergy prevention counselling into the 4-month well-child visit.